Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The lysosomal membrane and its associated lipid rafts are specialized microdomains within the lysosomal bilayer enriched in cholesterol, sphingolipids, and specific proteins like Lysosomal-associated membrane proteins (Boya & Kroemer, 2008). These rafts serve as critical platforms for the assembly of signaling complexes, most notably the mTORC1 complex, which regulates cell growth and metabolism in response to nutrient availability (Zoncu et al., 2011). In many cancer cells, the lysosomal membrane is destabilized, making it a vulnerable target for lysosomotropic agents that induce lysosomal membrane permeabilization (LMP) and subsequent programmed cell death (Boya & Kroemer, 2008). Additionally, defects in the lipid composition of these rafts are central to the pathogenesis of lysosomal storage disorders, such as Niemann-Pick type C, where cholesterol accumulation disrupts normal trafficking (Platt et al., 2012). Therapeutic strategies targeting these domains include small molecules that alter lysosomal pH, stabilize or destabilize the membrane, or modulate lipid metabolism to restore homeostasis (Settembre et al., 2013). Drugs like hydroxychloroquine and siramesine exploit these properties to treat autoimmune diseases or investigate anti-tumor effects by disrupting lysosomal integrity (Boya & Kroemer, 2008).
Induction of lysosomal membrane permeabilization (LMP), inhibition of lysosomal acidification, and modulation of lipid-protein interactions within membrane microdomains.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysosomal membrane lipid raft.